Joel S. Marcus, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 36,578 shares at $42.27 ($1.5M) on 2021-06-14, disclosed to the SEC on 2021-06-15.
Open-market sale of $1.5M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $42.27 | 18,289 | $773K | 50.0% |
| 2 | $42.27 | 18,289 | $773K | 50.0% |
| Total | $42.27 avg | 36,578 | $1.5M | 100% |
| Filing → |
| ARE | BUY | 2026-05-07 | $348K | — | Filing → |
| ARE | BUY | 2026-05-06 | $320K | — | Filing → |
| ARE | BUY | 2026-05-05 | $410K | — | Filing → |